Can a supplement protocol flush out environmental toxins and boost health?

NCT ID NCT07753798

Not yet recruiting Disease control Sponsor: OvationLab Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether two CellCore supplement protocols can help adults with high levels of environmental toxins in their bodies. Participants will take one of two supplement regimens for four months, and researchers will measure changes in urinary toxin levels and self-reported physical and mental health, as well as fatigue. The goal is to see if these supplements support the body's natural detoxification processes and improve overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CellCore supplement protocols (Foundational Protocol or BioToxin Binder & Drainage Activator)
What this could lead to: If effective, these supplements could offer a natural way to reduce the body's toxic burden and improve physical and mental well-being.
What could go wrong: This is a small, early-stage study without a placebo group, so results may not be conclusive or apply broadly. Supplements can also have side effects or interact with other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENVIRONMENTAL TOXINS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENVIRONMENTAL TOXINS GENERAL HEALTH

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

OvationLab

Richmond, Virginia, 23220, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.